Literature DB >> 17973891

Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.

Kathleen Janssen1, Georges P H Lucker, Ronald H Houwing, R van Rijssel.   

Abstract

Epidermodysplasia verruciformis (EV) is a rare heritable disease characterized by an unusual susceptibility to infection with specific types of human papillomavirus and a propensity for developing skin malignant tumors. Partial defects in cell-mediated immunity have been demonstrated in this disease. Here, we describe a patient with EV who was treated unsuccessfully with imiquimod.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973891     DOI: 10.1111/j.1365-4632.2007.03513.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.

Authors:  Monika Oldak; Liv Tolzmann; Artur Wnorowski; Marta Justyna Podgórska; Steffi Silling; Rongtuan Lin; John Hiscott; Cornelia Sigrid Lissi Müller; Thomas Vogt; Hans Smola; Sigrun Smola
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 2.  [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].

Authors:  A Heratizadeh; B Völker; E Kupsch; K Wichmann; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

3.  Sk India Quiz 26: Hypopigmented papules in a human immunodeficiency virus-positive patient.

Authors:  Lalit Kumar Gupta; Manisha Balai; Ashok Kumar Khare; Asit Mittal
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.